Tobramycin: Clinical Trials

18 trials of Tobramycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 3 terminated, 1 recruiting. 18 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 318Completed 14, Terminated 3, Recruiting 1

Follow Tobramycin: new trials by email Literature Review of Tobramycin trials Research Report on Tobramycin

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antibiotic Loaded Cement After TKA
total knee arthroplasty, Tobramycin, Gentamicin - Total Knee Arthoplasty
Phase 3CompletedRothman Institute Orthopaedics502022-06-202024-04-30
Tobramycin Injection to Prevent Infection in Open Fractures
Tobramycin Injection - Wound Infection, Fractures, Open
Phase 3CompletedMassachusetts General Hospital6002022-01-102026-09-16
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Standard of care, Vancomycin and Tobramycin - Post Operative Surgical Site Infection
Phase 3RecruitingMajor Extremity Trauma Research Consortium6002021-05-072026-07-22
Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis
Tobi Inhalant Product, Nebcin - Cystic Fibrosis
Phase 3TerminatedUniversity Hospital, Lille232017-06-132021-09-05
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis
Phase 3CompletedThe George Institute200102017-05-012023-08-14
Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients
Tobramycin nebulized nasally, Physiologic serum nebulized nasally - Cystic Fibrosis, Rhinosinusitis
Phase 3TerminatedVirginie ESCABASSE862017-02-162023-02-15
Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures
Tobramycin, Placebo: normal saline - Fractures, Open
Phase 3TerminatedUniversity of Virginia112015-07-012023-06-15
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
Loteprednol and tobramycin, Tobramycin and dexamethasone - Conjunctivitis, Keratitis
Phase 3CompletedBausch & Lomb Incorporated3572009-10-012012-02-28
A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
tobramycin - Cystic Fibrosis
Phase 3CompletedChiesi Farmaceutici S.p.A.2092009-09-012020-07-31
A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
tobramycin / Bramitob, tobramycin / TOBI - Cystic Fibrosis
Phase 3CompletedChiesi Farmaceutici S.p.A.3242009-04-012018-06-27
Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.
T1225, Tobramycin - Purulent Bacterial Conjunctivitis
Phase 3CompletedLaboratoires Thea2862008-12-012014-10-29
Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
Aztreonam for Inhalation Solution (AZLI), Tobramycin Inhalation Solution (TIS) - Cystic Fibrosis
Phase 3CompletedGilead Sciences2742008-08-012011-07-04
Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin
tobramycin - Pseudomonas Infections
Phase 3CompletedNovartis502008-02-012017-02-24
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Tobramycin 0.3%/Dexamethasone 0.05%, TOBRADEX - Ocular Inflammation Associated With Blepharaconjunctivitis
Phase 3CompletedAlcon Research2212007-10-012010-03-02
A Bioequivalence Study of Tobradex AF
Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension, Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX) - Cataract
Phase 3CompletedAlcon Research9952006-04-012012-03-05
A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
Prednisolone and Tobramycin, Prednisolone - Eye Infections, Postoperative Complications
Phase 3CompletedBausch & Lomb Incorporated1322005-07-012013-03-15
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
AzaSite, Tobramycin - Bacterial Conjunctivitis
Phase 3CompletedMerck Sharp & Dohme LLC7432004-07-012013-12-16
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
tobramycin - Cystic Fibrosis, Bacterial Infection
Phase 3CompletedFDA Office of Orphan Products Development2001995-06-012015-03-25

Conditions studied

Cystic Fibrosis (6)  ·  Conjunctivitis (2)  ·  Eye Infections (2)  ·  Fractures, Open (2)  ·  Pseudomonas Infections (2)  ·  Bacterial Infections (1)  ·  Blepharitis (1)  ·  Cataract (1)  ·  Communicable Diseases (1)  ·  Conjunctivitis, Bacterial (1)  ·  Critical Illness (1)  ·  Genetic Diseases, Inborn (1)  ·  Immune System Diseases (1)  ·  Keratitis (1)  ·  Lung Diseases (1)

Sponsors

Alcon Research (2)  ·  Bausch & Lomb Incorporated (2)  ·  Chiesi Farmaceutici S.p.A. (2)  ·  FDA Office of Orphan Products Development (1)  ·  Gilead Sciences (1)  ·  Laboratoires Thea (1)  ·  Major Extremity Trauma Research Consortium (1)  ·  Massachusetts General Hospital (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Novartis (1)  ·  Rothman Institute Orthopaedics (1)  ·  The George Institute (1)  ·  University Hospital, Lille (1)  ·  University of Virginia (1)  ·  Virginie ESCABASSE (1)

Countries

United States (9)  ·  France (6)  ·  Germany (3)  ·  Poland (2)  ·  Spain (2)  ·  Ukraine (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Ireland (1)

Top investigators

Henryk Mazurek, Doctor (2)  ·  Alan Bruce Montgomery (1)  ·  Anthony Gordon, MD FRCA (1)  ·  Anthony R Carlini, MS (1)  ·  Arun Aneja, MD, PhD (1)  ·  Brian Cuthbertson, MD FRCA (1)  ·  Esther Chu (1)  ·  John Myburgh, MBBCh PhD (1)  ·  Mark Bresnik, MD (1)  ·  Micahel J Bosse, MD (1)  ·  Michael Brubaker, BSN MPH (1)  ·  Rachel Seymour, PhD (1)  ·  Renan C Castillo, PhD (1)

Results publications

PMID 24464974, PMID 17652708, PMID 21129208, PMID 22256909, PMID 22985692, PMID 23352693, PMID 24207137, PMID 26626719, PMID 35390177, PMID 36286097, PMID 37982826, PMID 38045525, PMID 41159880, PMID 42642777

NIH funding

2008 (1), 2014 (1)